Effectiveness and Safety of Adding Basal Insulin Glargine in Patients with Type 2 Diabetes Mellitus Exhibiting Inadequate Response to Metformin and DPP-4 Inhibitors with or without Sulfonylurea
Open Access
- 1 January 2019
- journal article
- research article
- Published by Korean Diabetes Association in Diabetes & Metabolism Journal
- Vol. 43 (4) , 432-446
Abstract
Kang YM, et al. Diabetes Metab J. 2019 Jan;43:e37. https://doi.org/10.4093/dmj.2018.0092Keywords
This publication has 23 references indexed in Scilit:
- Dipeptidyl peptidase‐4 inhibitors and HbA1c target of <7% in type 2 diabetes: meta‐analysis of randomized controlled trialsDiabetes, Obesity and Metabolism, 2011
- Efficacy and safety of insulin detemir once daily in combination with sitagliptin and metformin: the TRANSITION randomized controlled trialDiabetes, Obesity and Metabolism, 2011
- Effect of insulin glargine on glycaemic control and weight in obese and non‐obese people with type 2 diabetes: data from the AT.LANTUS trialDiabetes, Obesity and Metabolism, 2010
- Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetesDiabetes, Obesity and Metabolism, 2009
- Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA 1c without causing weight gain or increased hypoglycaemiaDiabetes, Obesity and Metabolism, 2009
- Early Insulin Treatment in Type 2 DiabetesDiabetes Care, 2009
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of TherapyDiabetes Care, 2009
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesNew England Journal of Medicine, 2008
- Pathogenesis of Type 2 DiabetesEndocrine Research, 2007
- Glucagon physiology and pathophysiology in the light of new advancesDiabetologia, 1985